Alkermes

Alkermes plc is a global biopharmaceutical company that seeks to develop innovative medicines in the field of neuroscience. The company has a portfolio of proprietary commercial products for the treatment of alcohol dependence, opioid dependence, schizophrenia and bipolar I disorder and a pipeline of clinical and preclinical candidates in development for neurological disorders. Headquartered in Dublin, Ireland, Alkermes has a research and development center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio. For more information, please visit Alkermes' website at www.alkermes.com.

Diversity & Inclusion | Alkermes

Equal Opportunity and Respect: Diversity, Inclusion and Belonging at Alkermes

Dec 27, 2023 11:25 AM ET

Our employees are the foundation upon which our business is built. Their expertise, intelligence and creativity drive our innovation, and their passion and commitment to excellence are the cornerstone of our success.

Videos

Responsible Business & Employee Engagement | Alkermes

Former Oncology Nurse Finds a New Path To Improve Patients' Lives

Dec 12, 2022 2:20 PM ET

Meet Michele, an Alkermes employee who uses her past experience as an oncology nurse to aid in her personal mission of helping to improve patients’ lives through research.

Awards, Ratings & Rankings | Alkermes

Alkermes Announces Recipients of 2022 Alkermes Inspiration Grants® Program

Nov 7, 2022 1:15 PM ET

Alkermes plc (Nasdaq: ALKS) announced the 2022 recipients of the Alkermes Inspiration Grants® program.

Health & Healthcare | Alkermes

47% of Heavy Drinkers Seek Treatment Because of a Family Member

Oct 3, 2022 3:30 PM ET

Did you know that 47% of heavy drinkers said they sought treatment because a family member expressed concerns?

Health & Healthcare | Alkermes

65% of Heavy Drinkers Are Concerned, yet Only 26% Seek Treatment

Sep 27, 2022 2:05 PM ET

65% of heavy drinkers responded “yes” when asked if they have ever been concerned about their drinking, yet only 26% have sought treatment.

Health & Healthcare | Alkermes

Did You Know a Person's Biology and Environment Can Increase Their Predisposition to Addiction?

Sep 14, 2022 12:15 PM ET

Anyone can develop AUD, however, certain factors like biology and environment may contribute to a person's predisposition.